DirectorMoves

Dec 06, 2023

∙ Paid

Directors & Boards the leader in news, analysis & governance in public & private company Boardrooms. Featured Article: New Year, New Approach: ESG in 2024 By Thomas O'Neil

Director and CEO Moves

Johnson & Johnson (NYSE: JNJ) $381.b NJ Eugene Woods joins Board CEO Advocate Health

Vertex Pharmaceuticals (NASDAQ: VRTX) $91.2b MA Ms. Nancy Thornberry joins …

This post is for paid subscribers